Dr. Lotan graduated with high honors from the University of Texas at Austin and with honors from Baylor College of Medicine in Houston. He trained in general surgery and urology at UT Southwestern ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Summit Therapeutics will supply ivonescimab for clinical research and Revolution Medicines will be the study sponsor. Each company will retain commercial rights to their respective compounds.

Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS (ON) Inhibitors with Ivonescimab in RAS Mutant Tumors ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

The university’s ability to make up for the paused NIH funds is expected to run out by the fall, multiple researchers told CNN. HHS didn’t respond to CNN’s questions about whether it or the NIH ...